Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedStar Georgetown Transplant Institute (MGTI) is a premier transplant center based in Washington, D.C., operating as a specialized division of MedStar Health. The institute is one of the highest-volume transplant programs in the United States, offering comprehensive services for kidney, liver, pancreas, and small bowel transplantation. MGTI is particularly noted for its expertise in pediatric transplantation, living donor programs, and the management of complex hepatobiliary diseases. By combining clinical practice with academic research through its affiliation with Georgetown University, the institute remains at the forefront of transplant medicine and surgical innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedStar Georgetown Transplant Institute.